Wave Life Sciences, Inc. (WVE)
3.175
-0.18
(-5.22%)
USD |
NASDAQ |
Oct 23, 16:00
3.175
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences Market Cap : 613.66M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 22, 2026 | 647.48M |
| October 21, 2026 | 651.35M |
| October 20, 2026 | 661.01M |
| October 19, 2026 | 612.69M |
| October 16, 2026 | 604.96M |
| October 15, 2026 | 616.56M |
| October 14, 2026 | 597.23M |
| October 13, 2026 | 606.89M |
| October 12, 2026 | 633.95M |
| October 09, 2026 | 668.74M |
| October 08, 2026 | 670.67M |
| October 07, 2026 | 684.20M |
| October 06, 2026 | 680.34M |
| October 05, 2026 | 724.79M |
| October 02, 2026 | 730.59M |
| October 01, 2026 | 749.92M |
| September 30, 2026 | 715.13M |
| September 29, 2026 | 703.53M |
| September 28, 2026 | 709.33M |
| September 25, 2026 | 730.59M |
| September 24, 2026 | 765.38M |
| September 23, 2026 | 763.45M |
| September 22, 2026 | 840.76M |
| September 21, 2026 | 822.40M |
| September 18, 2026 | 840.76M |
| Date | Value |
|---|---|
| September 17, 2026 | 858.15M |
| September 16, 2026 | 870.72M |
| September 15, 2026 | 862.02M |
| September 14, 2026 | 885.21M |
| September 11, 2026 | 887.14M |
| September 10, 2026 | 902.61M |
| September 09, 2026 | 929.67M |
| September 08, 2026 | 948.99M |
| September 04, 2026 | 939.33M |
| September 03, 2026 | 908.40M |
| September 02, 2026 | 943.19M |
| September 01, 2026 | 960.59M |
| August 31, 2026 | 947.06M |
| August 28, 2026 | 974.12M |
| August 27, 2026 | 997.31M |
| August 26, 2026 | 1.011B |
| August 25, 2026 | 1.015B |
| August 24, 2026 | 989.58M |
| August 21, 2026 | 1.022B |
| August 20, 2026 | 1.015B |
| August 19, 2026 | 1.047B |
| August 18, 2026 | 1.022B |
| August 17, 2026 | 983.78M |
| August 14, 2026 | 1.046B |
| August 13, 2026 | 1.005B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 31.31M |
| CorMedix, Inc. | 610.46M |
| Eloxx Pharmaceuticals, Inc. | 51.83M |
| Breakthrough Chemistry, Inc. | 0.9729M |
| BioStem Technologies, Inc. | 28.16M |
Market Cap Related Metrics
| PS Ratio | 9.132 |
| PEG Ratio | -0.1344 |
| Price to Book Value | 1.353 |
| Price | 3.175 |
| Earnings Yield | -34.22% |
| PEGY Ratio | -0.1344 |